Arete Wealth Advisors’s Recursion Pharmaceuticals RXRX Stock Holding History

Arete Wealth Advisors’s Portfolio RXRX Stock Details RXRX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell
2025 Q4	$104K	Sell
2025 Q3	$193K	Sell
2025 Q2	$458K	Buy
2025 Q1	$68K	Buy
2024 Q4	$78K	Hold
2024 Q3	$77K	Buy